NCT06014606View on ClinicalTrials.gov

Learning and Decision-making

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

April 30, 2023

Study Completion Date

August 16, 2023

Conditions
Motivation
Interventions
DRUG

placebo

oral formulation

DRUG

haloperidol 2mg

oral formulation

DRUG

propranolol 40mg

oral formulation

Trial Locations (1)

Unknown

Maastricht University, Maastricht

All Listed Sponsors
lead

Maastricht University

OTHER

NCT06014606 - Learning and Decision-making | Biotech Hunter | Biotech Hunter